Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$35.61 - $76.23 $1,709 - $3,659
-48 Reduced 16.11%
250 $10,000
Q1 2022

May 11, 2022

SELL
$57.56 - $82.54 $17,958 - $25,752
-312 Reduced 51.15%
298 $21,000
Q4 2021

Jan 10, 2022

BUY
$72.5 - $100.68 $7,975 - $11,074
110 Added 22.0%
610 $47,000
Q3 2021

Nov 24, 2021

SELL
$90.24 - $124.05 $1,624 - $2,232
-18 Reduced 3.47%
500 $48,000
Q2 2021

Jul 30, 2021

SELL
$93.66 - $139.27 $4,683 - $6,963
-50 Reduced 8.8%
518 $64,000
Q1 2021

Apr 29, 2021

SELL
$116.57 - $155.01 $5,828 - $7,750
-50 Reduced 8.09%
568 $75,000
Q4 2020

Jan 15, 2021

SELL
$99.61 - $142.12 $29,883 - $42,636
-300 Reduced 32.68%
618 $82,000
Q2 2020

Jul 10, 2020

BUY
$55.75 - $92.75 $1,003 - $1,669
18 Added 2.0%
918 $80,000
Q1 2020

Apr 15, 2020

SELL
$37.9 - $104.44 $3,903 - $10,757
-103 Reduced 10.27%
900 $52,000
Q3 2019

Oct 25, 2019

SELL
$90.37 - $122.49 $5,151 - $6,981
-57 Reduced 5.38%
1,003 $91,000
Q2 2019

Aug 07, 2019

BUY
$89.51 - $118.04 $14,321 - $18,886
160 Added 17.78%
1,060 $124,000
Q1 2019

Apr 29, 2019

BUY
$61.98 - $96.5 $6,198 - $9,650
100 Added 12.5%
900 $78,000
Q3 2018

Oct 30, 2018

BUY
$48.29 - $80.6 $38,632 - $64,479
800 New
800 $63,000
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $30,272 - $55,967
-800 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$39.82 - $57.53 $3,982 - $5,753
100 Added 14.29%
800 $31,000
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $4,649 - $6,051
100 Added 16.67%
700 $35,000
Q2 2017

Aug 08, 2017

BUY
N/A
600
600 $22,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.